| Revenue growth | 38.2% YoY reported; 40.0% YoY on LFL basis. |
|---|---|
| Margins | Gross margin up 147bps to 11.4%; EBITDA margin reached 5.0%. |
| Demand visibility | Organic growth running ahead of IPM growth. |
| Management confidence | High confidence on delivering on guidance for rest of the year. |
Growth
Revenue rose 38% YoY; EBITDA increased 94% to ₹97 Cr; PAT (to owners) grew 37% to ₹38.2 Cr.
Outlook
MedTech revenue expected to cross ₹1,000 Cr in FY27. High confidence in delivering on guided trajectory.
Risks
Fragmented market competition and potential impact from conscious exits in certain low-margin businesses.
Last quarter's promises, checked
Delivered
- Guided 30% LFL revenue growth → delivered 31.5% (= BEAT)
- Guided 4% EBITDA margin → delivered 4% (= BEAT)
- Guided operating cash flow optimization → delivered ₹96.2 Cr OCF (= BEAT)
Investor Presentation filed with BSE, NSE: ENTERO. Summary written with AI assistance from the document.
Entero Healthcare Solutions Ltd: key numbers
- Share price
- ₹1,733.10
- Market cap
- ₹7,543 Cr
- Revenue (annual)
- ₹6,591 Cr
- Net profit (annual)
- ₹115.0 Cr
- P/E (TTM)
- 60.1×Sector 53.1×
- Promoter holding
- 52.40%-0.02% QoQ
- FII holding
- 4.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Entero Healthcare Solutions Ltd
All →Entero Healthcare Solutions Capital Structure Change
Surbhi Singh (Prasid Uno Family Trust), a non-promoter, sold 21.30 lakh Entero Healthcare shares via bulk/block deals. Stake fell from 7.94% to 3.05%; no transaction value disclosed.
Entero Healthcare Solutions Legal & Regulatory
Entero Healthcare Solutions reported a GST penalty of Rs. 0.13 Crore imposed on its subsidiary, ACE Cardiopathy Solutions, for non-generation of an E-Invoice.
- Value
- ₹0.13 Cr
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions Ltd filed its quarterly shareholding pattern for the period ended March 31, 2026, as per regulatory requirements.
Entero Healthcare Solutions Capital Structure Change
Prasid Uno Family Trust acquired 10,88,500 shares (2.50%) of Entero Healthcare Solutions Ltd via a block deal. Post-transaction, their total stake is 6.93%.
Entero Healthcare Solutions Management Change
Entero Healthcare Solutions announced the completion of the tenure of Non-Executive Independent Director Mr. Rajesh Shashikant Dalal, effective from August 24, 2026.
Entero Healthcare Solutions Annual General Meeting
Entero Healthcare Solutions Ltd held its 8th Annual General Meeting on August 19, 2026. Members approved all resolutions, including financial statement adoption and director re-appointments.